Licata G, Balato A, Argenziano G, Giorgio CM. Dupilumab as a targeted therapeutic strategy for Th2-driven cutaneous manifestations in Kimura disease. Dermatol Reports [Internet]. 2026 Jul. 22 [cited 2026 Jul. 26];. Available from: https://journals.pagepress.net/dr/article/view/10839